Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

krka d.d. - iceland moss thick extract - syrup - 6mg/ml 150ml glass bottle and measuring spoon

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - flumethrin - topical solution/suspension - flumethrin pyrethroid active 10.0 g/l - parasiticides

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco europe ltd - milbemycin oxime (a3 and a4), praziquantel - chewable tablet - anthelmintic - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco europe ltd - milbemycin oxime (a3 and a4), praziquantel - tablet - anthelmintic - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco europe ltd - milbemycin oxime (a3 and a4), praziquantel - coated tablet - anthelmintic - cats

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco europe ltd - milbemycin oxime (a3 and a4), praziquantel - tablet - anthelmintic - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco europe ltd - milbemycin oxime (a3 and a4), praziquantel - coated tablet - anthelmintic - cats

United Kingdom - English - VMD (Veterinary Medicines Directorate)

elanco europe ltd. - milbemycin oxime (a3 and a4), praziquantel - chewable tablet - anthelmintic - dogs

European Union - English - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - obesity - antiobesity preparations, excl. diet products - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

United States - English - NLM (National Library of Medicine)

almatica pharma inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen 375 mg - naprelan tablets are indicated for the treatment of: • rheumatoid arthritis (ra) • osteoarthritis (oa) • ankylosing spondylitis (as) • tendinitis, bursitis • acute gout • primary dysmenorrhea (pd) • the relief of mild to moderate pain [see warnings and precautions (5)] . naprelan is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8) ] - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1) ] risk summary use of nsaids, including naprelan, can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios an